László Gulácsi : Citation Profile


Are you László Gulácsi?

Budapesti Corvinus Egyetem

5

H index

1

i10 index

69

Citations

RESEARCH PRODUCTION:

23

Articles

RESEARCH ACTIVITY:

   7 years (2007 - 2014). See details.
   Cites by year: 9
   Journals where László Gulácsi has often published
   Relations with other researchers
   Recent citing documents: 2.    Total self citations: 10 (12.66 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pgu509
   Updated: 2024-11-04    RAS profile: 2023-05-06    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with László Gulácsi.

Is cited by:

Baji, Petra (18)

Brodszky, Valentin (15)

Baert, Stijn (6)

Hermann, Zoltan (5)

Pavlova, Milena (4)

Péntek, Márta (3)

Gitto, Lara (2)

Obrizan, Maksym (2)

Brouwer, Werner (2)

Mennini, Francesco Saverio (2)

Williams, Colin (1)

Cites to:

Péntek, Márta (10)

Boncz, Imre (8)

Brodszky, Valentin (7)

Baji, Petra (6)

Pavlova, Milena (6)

Culyer, Anthony (4)

van Exel, Job (3)

Brazier, John (3)

Brouwer, Werner (3)

McCabe, Christopher (2)

Claxton, Karl (2)

Main data


Where László Gulácsi has published?


Journals with more than one article published# docs
The European Journal of Health Economics18
Society and Economy2
Health Policy2

Recent works citing László Gulácsi (2024 and 2023)


YearTitle of citing document
2023Priority setting in the German healthcare system: results from a discrete choice experiment. (2023). Mentzakis, Emmanouil ; Paolucci, F ; Fiorentini, G ; Baji, P ; Meusel, V. In: International Journal of Health Economics and Management. RePEc:kap:ijhcfe:v:23:y:2023:i:3:d:10.1007_s10754-023-09347-y.

Full description at Econpapers || Download paper

Works by László Gulácsi:


YearTitleTypeCited
2012Comparing cost-sharing practices for pharmaceuticals and health care services among four central European countries In: Society and Economy.
[Full Text][Citation analysis]
article1
2012Preferences of Hungarian consumers for quality, access and price attributes of health care services — result of a discrete choice experiment In: Society and Economy.
[Full Text][Citation analysis]
article7
2011User fees for public health care services in Hungary: Expectations, experience, and acceptability from the perspectives of different stakeholders In: Health Policy.
[Full Text][Citation analysis]
article7
2009Quality management and patient safety: Survey results from 102 Hungarian hospitals In: Health Policy.
[Full Text][Citation analysis]
article2
2007Verseny az egészségügyben. Egyesült államokbeli és nyugat-európai példák In: Közgazdasági Szemle (Economic Review - monthly of the Hungarian Academy of Sciences).
[Full Text][Citation analysis]
article0
2010The disease burden of colorectal cancer in Hungary In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2010Future challenges for health economics and health technology assessment of biological drugs In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2012Health economics and health technology assessment in Central and Eastern Europe: a dose of reality In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3
2014Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European countries In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2014Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article4
2014Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2014Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article7
2014Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article7
2014Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article10
2014Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2014Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2014Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2014Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2014Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article5
2014Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2014HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2014The link between past informal payments and willingness of the Hungarian population to pay formal fees for health care services: results from a contingent valuation study In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article4
2007The time for cost-effectiveness in the new European Union member states: the development and role of health economics and technology assessment in the mirror of the Hungarian experience In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team